News
Loneliness tied to elevated risk for valvular heart disease
2+ hour, 47+ min ago (266+ words) People reporting a high level of loneliness, but not those with social isolation, had elevated risk for developing valvular heart disease, according to the results of a prospective cohort study. Zhu and colleagues analyzed data from 462, 917 participants (median age, 58 years;…...
Sensor-enabled smart device may detect PJI before diagnosis
20+ hour, 49+ min ago (294+ words) NEW ORLEANS " Use of a sensor-enabled smart device implanted at the time of total knee arthroplasty may detect periprosthetic joint infection before diagnosis, according to results presented here. "By monitoring patients" recovery with a smart device, we noticed a change…...
EYE7 glasses launch with AI assistants for people with vision loss
21+ hour, 34+ min ago (191+ words) Eyedaptic launched EYE7, a new model of smart glasses featuring interactive AI assistants to aid people with vision loss, according to a press release. Using speakers and microphones built into the glasses, AI assistants can be prompted with hands-free voice commands…...
Chat GPT demonstrates efficiency in clinical trial recruitment
6+ mon, 2+ week ago (697+ words) Multiple versions of Chat GPT demonstrated efficacy in identifying eligible patients for clinical trial recruitment, showing potential to complement manual chart reviews, according to a study published in Machine Learning: Health. Improving clinical trial recruitment has been an ongoing challenge…...
VIDEO: AI takes aim at automated patient chart review to "maximize best care for patients
8+ mon, 5+ day ago (217+ words) One AI-powered health care data company is leveraging its proprietary large language model-based platform to automate chart review to prescreen potential candidates for clinical trials and observational studies. Synapsis AI from Dyania Health " based in Jersey City, New Jersey " is…...
Acoramidis reduces cumulative CV outcomes in patients with cardiac amyloidosis
6+ mon, 2+ week ago (322+ words) Acoramidis reduced the cumulative burden of cardiovascular outcomes at 30 months in patients with transthyretin amyloid cardiomyopathy, according to new data from the ATTRibute-CM trial. The analysis included 611 patients with transthyretin amyloid cardiomyopathy (ATTR-CM; mean age, 77 years; 91% men; 88% white). The primary…...
Surgeon highlights advantages of using Unity platform
10+ mon, 1+ week ago (266+ words) LOS ANGELES " With the recently launched Unity system, Alcon aims to allow ophthalmologists to perform vitreoretinal cataract surgery and cataract surgery on the same platform. According to a company press release, the platform offers the combined Unity Vitreoretinal Cataract System…...
Vutrisiran improves cardiac amyloidosis endpoints regardless of disease severity
1+ year, 1+ week ago (504+ words) CHICAGO " Vutrisiran improved mortality and recurrent CV risks independent of disease severity and improved several other endpoints for a broad spectrum of patients with transthyretin amyloidosis with cardiomyopathy, subgroup analyses show. The monotherapy population included 395 patients with ATTR-CM who were…...
VIDEO: Expert discusses current treatment options for ATTR amyloidosis with cardiomyopathy
6+ mon, 2+ week ago (469+ words) Naeem is a postdoctoral research fellow in the department of cardiology at Massachusetts General Hospital and Harvard University School of Medicine. VIDEO: Expert discusses current treatment options for ATTR amyloidosis with cardiomyopathy Editor's note: This is an automatically generated transcript....
FDA rejects biologics license application for apitegromab
6+ mon, 2+ week ago (263+ words) The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock. In a press release, Scholar Rock stated that the FDA's Complete Response Letter (CRL) cited "adverse conditions" discovered during an…...